Barclays’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200M | Buy |
|
|||||
|
2025
Q1 | $11.5M | Sell |
|
|||||
|
2024
Q4 | $16.5M | Buy |
|
|||||
|
2024
Q3 | $15.8M | Buy |
|
|||||
|
2024
Q2 | $5.74M | Sell |
|
|||||
|
2024
Q1 | $6.2M | Sell |
|
|||||
|
2023
Q4 | $13.5M | Buy |
|
|||||
|
2023
Q3 | $6.36M | Buy |
|
|||||
|
2023
Q2 | $6.59M | Buy |
|
|||||
|
2023
Q1 | $4.56M | Sell |
|
|||||
|
2022
Q4 | $5.44M | Buy |
|
|||||
|
2022
Q3 | $4.87M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Sell |
|
|||||
|
2022
Q1 | $1.78M | Sell |
|
|||||
|
2021
Q4 | $7.77M | Buy |
|
|||||
|
2021
Q3 | $4.53M | Buy |
|
|||||
|
2021
Q2 | $949K | Sell |
|
|||||
|
2021
Q1 | $5.41M | Buy |
|
|||||
|
2020
Q4 | $3.67M | Sell |
|
|||||
|
2020
Q3 | $3.74M | Sell |
|
|||||
|
2020
Q2 | $9.54M | Buy |
|
|||||
|
2020
Q1 | $3.35M | Sell |
|
|||||
|
2019
Q4 | $8.69M | Buy |
|
|||||
|
2019
Q3 | $2.06M | Sell |
|
|||||
|
2019
Q2 | $3.3M | Buy |
|
|||||
|
2019
Q1 | $2.22M | Buy |
|
|||||
|
2018
Q4 | $181K | Sell |
|
|||||
|
2018
Q3 | $2.4M | Buy |
|
|||||
|
2018
Q2 | $1.27M | Buy |
|
|||||
|
2018
Q1 | $1.1M | Buy |
|
|||||
|
2017
Q4 | $698K | Buy |
|
|||||
|
2017
Q3 | $203K | Buy |
|
|||||
|
2017
Q2 | $128K | Sell |
|
|||||
|
2017
Q1 | $618K | Buy |
|
|||||
|
2016
Q4 | $82K | Buy |
|
|||||
|
2016
Q3 | $7K | Sell |
|
|||||
|
2016
Q2 | $7K | Buy |
|
|||||
|
2016
Q1 | $2K | Sell |
|
|||||
|
2015
Q4 | $12K | Sell |
|
|||||
|
2015
Q3 | $14K | Sell |
|
|||||
|
2015
Q2 | $21K | Buy |
|